Schedule 13D ownership disclosure

SENESCO TECHNOLOGIES INC

Security class unavailable · CUSIP: 817208507

Event date: 2014-05-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,400,970
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-14-034026
Form type
SC 13D
Filer
Eloxx Pharmaceuticals, Inc.
CIK
CIK 1035354
Filed
May 29, 2014
Reporting period
May 16, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub